Pfizer earned $3.5 billion on COVID-19 vaccine in first quarter

Pfizer's COVID-19 vaccine earned the company $3.5 billion in the first three months of this year, representing nearly a quarter of its total revenue, the company announced ahead of its earnings call Tuesday.
Read more: https://thehill.com/business-a-lobbying/551651-pfizer-earned-35-billion-on-covid-vaccine-in-first-quarter?source=Snapzu